Is Phosphodiesterase Inhibition Arrhythmogenic? Electrophysiologic Effects in Pithed Rats and in Normoxic and Hypoxic Rabbit Atria of Enoximone, a New Cardiotonic Agent
- 1 February 1987
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 27 (2) , 91-100
- https://doi.org/10.1002/j.1552-4604.1987.tb02167.x
Abstract
The positive inotropic and chronotropic actions of enoximone were confirmed. At concentrations within the clinical range, enoximone prolonged the chronotropic and hypotensive action of isoproterenol in pithed rats. Very high doses of both enoximone and isoproterenol caused ventricular fibrillation in only one of six rats. In isolated rabbit atria, the maximum frequency at which pacing stimuli were followed 1:1 was increased by enoximone, and atrial flutter was consistently induced, then terminated by greatly suprathreshold stimulation. Enoximone significantly shortened action potential duration (APD), but did not exacerbate the APD‐shortening induced by hypoxia. Since such hypoxia‐induced shortening occurred in the presence of glucose 11 mmol/L and oxygen 20%, it was concluded that it was unlikely to have been caused by the opening of ATP‐regulated potassium channels. These animal experiments suggest that enoximone, at concentrations encountered clinically in humans, does not have any electrophysiologic actions that would be likely to increase the probability of arrhythmias.This publication has 17 references indexed in Scilit:
- Adenine nucleotides and vulnerability to ventricular fibrillationJournal of Molecular and Cellular Cardiology, 1986
- Preload and Afterload Reduction in Treating Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1984
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043Journal of Cardiovascular Pharmacology, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIABritish Journal of Pharmacology, 1982
- DIFFERENTIAL ACTIONS ON RABBIT NODAL, ATRIAL, PURKINJE CELL AND VENTRICULAR POTENTIALS OF MELPERONE, A BRADYCARDIC AGENT DELAYING REPOLARIZATION: EFFECTS OF HYPOXIABritish Journal of Pharmacology, 1982
- The effects of various fatty acids on action potential shortening during sequential periods of ischaemia and reperfusionJournal of Molecular and Cellular Cardiology, 1980
- Biochemical aspects of arrhythmogenesis and ventricular fibrillationThe American Journal of Cardiology, 1979
- The effects of palmitate on intracellular potentials recorded from langendorff-perfused guinea-pig hearts in normoxia and hypoxia, and during perfusion at reduced rate of flowJournal of Molecular and Cellular Cardiology, 1977